The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting

Inclusion Criteria:

Patients

• Aged ≥18 years at the time of enrollment in the study
• Resident of the US, Germany, or Japan
• Able to read, speak, and understand English, German or Japanese
• Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC)

Physicians

• Resident of the US, Germany, or Japan
• Lung cancer-treating physician specialized in one of the following medical areas: oncology, pneumonology, thoracic surgery, or radiology
• Treated at least three new patients with resectable NSCLC in the past year

Exclusion Criteria:

Patients

• Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
• Being diagnosed with another malignancy alongside NSCLC
• Not willing to be audio-recorded during the interview

Physicians

• Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
• Not willing to be audio-recorded during the interview

Adults participants with a diagnosis of resectable NSCLC and physicians treating patients with resectable NSCLC residing in US, Germany or Japan.